更新日期 | 產(chǎn)品編號 | 品牌 | 產(chǎn)品信息 | CAS號 | MDL號 | 規(guī)格與純度 | 包裝 | 價(jià)格 | 庫存信息 | 操作 |
2025/05/22
|
HY-76688
|
|
3-(5,6-二氫-4H-吡咯并[3,2,1-IJ]喹啉-1-基)-4-(1H-吲哚-3-基)吡咯烷 (Rac)-Tivantinib
|
1239986-50-5
|
|
|
5 mg
|
300元
|
In-stock
|
詳細(xì)
|
2025/05/22
|
HY-76688
|
|
3-(5,6-二氫-4H-吡咯并[3,2,1-IJ]喹啉-1-基)-4-(1H-吲哚-3-基)吡咯烷 (Rac)-Tivantinib
|
1239986-50-5
|
|
|
10 mM * 1 mLin DMSO
|
330元
|
In-stock
|
詳細(xì)
|
2025/05/22
|
HY-76688
|
|
3-(5,6-二氫-4H-吡咯并[3,2,1-IJ]喹啉-1-基)-4-(1H-吲哚-3-基)吡咯烷 (Rac)-Tivantinib
|
1239986-50-5
|
|
|
10 mg
|
510元
|
In-stock
|
詳細(xì)
|
2025/05/22
|
HY-76688
|
|
3-(5,6-二氫-4H-吡咯并[3,2,1-IJ]喹啉-1-基)-4-(1H-吲哚-3-基)吡咯烷 (Rac)-Tivantinib
|
|
|
|
25 mg
|
1090元
|
In-stock
|
詳細(xì)
|
2025/05/22
|
HY-76688
|
|
3-(5,6-二氫-4H-吡咯并[3,2,1-IJ]喹啉-1-基)-4-(1H-吲哚-3-基)吡咯烷 (Rac)-Tivantinib
|
1239986-50-5
|
|
|
50 mg
|
1750元
|
In-stock
|
詳細(xì)
|
2025/05/22
|
HY-76688
|
|
3-(5,6-二氫-4H-吡咯并[3,2,1-IJ]喹啉-1-基)-4-(1H-吲哚-3-基)吡咯烷 (Rac)-Tivantinib
|
1239986-50-5
|
|
|
100 mg
|
2800元
|
In-stock
|
詳細(xì)
|
2024/08/19
|
HY-76688
|
|
(Rac)-Tivantinib
|
|
|
|
200 mg
|
6519元
|
In-stock
|
詳細(xì)
|